J&J: Ibrutinib Was Well Tolerated as a Long-Term Treatment and No New Safety Signals Emerged
強生:伊布替尼作爲長期治療很好地耐受了,並且沒有出現新的安全信號
J&J: Ibrutinib Was Well Tolerated as a Long-Term Treatment and No New Safety Signals Emerged
強生:伊布替尼作爲長期治療很好地耐受了,並且沒有出現新的安全信號
譯文內容由第三人軟體翻譯。